Characteristics of age-related macular degeneration in Chinese population

Chinese Journal of Ophthalmology

Volumn 45, Issue 5, 2009, Pages 393-395

  Liu, Ning Pu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

China; Ethnic groups; Macular degeneration

Indexed keywords

COMPLEMENT FACTOR H;

ARTICLE; ASIAN; ETHNOLOGY; GENETICS; GENOTYPE; HUMAN; PROGNOSIS; RETINA MACULA DEGENERATION;

ASIAN CONTINENTAL ANCESTRY GROUP; COMPLEMENT FACTOR H; GENOTYPE; HUMANS; MACULAR DEGENERATION; PROGNOSIS;

EID: 67650138632     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.04124081.2009.05.003     Document Type: Article

References (16)

1. Friedman DS, Katz J., Bressler NM, et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore eye survey. Ophthalmology, 1999, 106:1049-1055.
2. Oshima Y., Ishibashi T., Murata T., et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol, 2001, 85:1153-1157.
3. Li Y., Xu L., Jonas JB, et al. Prevalence of age-related maculopathy in the adult population in China; the Beijing eye study. Am J Ophthalmol, 2006, 142:788-793.
4. Liu Y., Wen F., Huang S., et al. Subtype lesions of neovascular agerelated macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol, 2007, 245:1441-1445.
5. Maruko I., Iida T., Saito M., et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol, 2007, 144:15-22.
6. Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol, 2004, 49:25-37.
7. Sivaprasad S., Membrey WL, Sivagnanavel V., et al. Second eye of patients with unilateral neovascular age-related macular degeneration:Caucasians vs Chinese. Eye, 2006, 20:923-926.
8. Xu Y., Guan N., Xu J., et al. Association of CFH, LOC387715, and YTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis, 2008, 14: 1373-1381.
9. Chen LJ, Liu DT, Tam PO, et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis, 2006, 12:1536-1542.
10. Lau LI, Chen SJ, Cheng CY, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular agerelated macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci, 2006, 47:3242-3246.
11. Nozaka M., Raisler BJ, Sakurai E., et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA, 2006, 103:2328-2333.
12. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol, 1999, 117:1329-1345.
13. Verteporfin in photodynamic therapy study group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration; two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2001, 131:541-560.
14. Yang N., Fan CM, Ho CK. Review of first year result of photodynamic therapy on age-related macular degeneration in Chinese population. Eye, 2006, 20:523-526.
15. (Chinese Source)
16. (Chinese Source)